Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

Home
/
update
/
details

Amgen Unveils New Technology and Innovation Hub in Hyderabad

NextEdge Admin

09 Aug 2024

2 min 5 sec

Amgen, a global biotechnology leader, is set to establish a new technology and innovation site in Hyderabad, marking a significant step in its global expansion strategy. Named Amgen India, the site will open in the fourth quarter of 2024 in Hitech City, spanning six floors and accommodating up to 3,000 employees.

Hyderabad was chosen for its renowned talent pool in medicine, life sciences, data sciences, and its advancing AI sector. The new facility will bolster Amgen’s digital capabilities, accelerating the development of innovative medicines. David M. Reese, M.D., Executive Vice President and Chief Technology Officer at Amgen, emphasized the strategic importance of this expansion, noting that the convergence of biotechnology and technology enables Amgen to operate with greater speed and efficiency.

Amgen India will focus initially on AI, data science, and life sciences, with plans to scale its global capabilities. Som Chattopadhyay has been appointed as the national executive to lead this expansion.

Telangana Chief Minister A. Revanth Reddy and Industries Minister Duddilla Sridhar Babu expressed pride in Hyderabad’s selection, highlighting the city's growing reputation as a life sciences hub. They emphasized the government’s commitment to partnering with Amgen for long-term success.

This new site strengthens Amgen’s global presence, furthering its mission to serve patients through innovation in biotechnology.